NeurAxis, Inc. (NRXS) Stock

NeurAxis, Inc. is a pioneering medical technology firm dedicated to advancing neuromodulation therapies aimed at alleviating chronic and debilitating conditions affecting children and adults across the United States. At the forefront of its innovations is IB-Stim, a percutaneous electrical nerve field stimulation system specifically designed for adolescents aged 11 to 18 suffering from functional abdominal pain associated with irritable bowel syndrome (IBS). This groundbreaking technology offers a non-invasive treatment option that targets pain management through electrical nerve stimulation.

In addition to developing cutting-edge therapies, NeurAxis, Inc. collaborates closely with healthcare providers, including hospitals and clinics, to ensure widespread access to its innovative solutions. Formerly known as Innovative Health Solutions, Inc., the company underwent a rebranding in March 2022 to NeurAxis, Inc., reflecting its commitment to advancing neurological care through technological innovation and therapeutic excellence.

Founded in 2011 and headquartered in Carmel, Indiana, NeurAxis, Inc. continues to expand its footprint in the medical technology sector. With a strong emphasis on research and development, the company remains dedicated to improving patient outcomes and enhancing quality of life through effective and accessible neuromodulation therapies.